SCHEMBL6608300

SCHEMBL6608300

CCCN(CCC)c1cc(C(N)=O)cc(-c2ncco2)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR3 P49019 2/20 0.36
HPGD P15428 1/20 0.33
S1PR1 P21453 2/20 0.33
S1PR3 Q99500 1/20 0.32
KDM5C P41229 2/20 0.32
KDM5B Q9UGL1 2/20 0.32
KDM4B O94953 1/20 0.32
TLR7 Q9NYK1 2/20 0.32
TLR8 Q9NR97 1/20 0.32
MCL1 Q07820 2/20 0.32
PRKD1 Q15139 1/20 0.32
PRKD2 Q9BZL6 1/20 0.32
CNR1 P21554 1/20 0.31
GLRA3 O75311 1/20 0.31
GLRB P48167 1/20 0.31
HRH4 Q9H3N8 2/20 0.31
ESR1 P03372 1/20 0.31
ESR2 Q92731 1/20 0.31
TSHR P16473 1/20 0.31
CCNK O75909 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6044654 0.77 BACE1 (0.39) KDM5CKDM5BCNR1KDM5A
SCHEMBL6043432 0.74 BACE1 (0.54)
SCHEMBL3353364 0.74 HCAR3 (0.48) HCAR3S1PR1S1PR3KDM5CKDM5B
Hydrochloric Acid SCHEMBL3855650 0.72 HCAR3 (0.47) HCAR3S1PR1S1PR3KDM5CKDM5B
SCHEMBL2712687 0.70 KDM5C (0.51) KDM5CKDM5BKDM4BKDM4C
SCHEMBL6608298 0.68 KDM5A (0.41) KDM5CKDM5BTLR7TLR8GLRA3
SCHEMBL3640416 0.67 GLRA3 (0.50) KDM5CKDM5BKDM4BPRKD1PRKD2
SCHEMBL3353484 0.64 GLRA3 (0.45) GLRA3GLRB
SCHEMBL16199856 0.64 HCAR3 (0.49) HCAR3TSHRAOC3
SCHEMBL3352698 0.64 HCAR3 (0.60) HCAR3S1PR1S1PR3KDM5CKDM5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1430032-A2 SUBSTITUTED AMIDES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS Elan Pharmaceuticals, Inc. (US) 2004-06-23 EP disclosed
WO-2003027068-A2 SUBSTITUTED AMINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS ELAN PHARMACEUTICALS, INC. (US) 2003-04-03 WO disclosed